ClinicalTrials.Veeva

Menu

Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX-2

I

Institute of HIV Research and Innovation Foundation, Thailand

Status

Enrolling

Conditions

ChemSex Users for YMSM

Treatments

Behavioral: Group1

Study type

Observational

Funder types

Other

Identifiers

NCT06741306
IHRI025

Details and patient eligibility

About

CLYMAX is a two-phase observational study that assess multiple aspects of chemsex and young men who have sex with men (YMSM).

Phase I of the study (CLYMAX,IRB No. 0695/65) was a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) assessing multiple aspects of chemsex, including the patterns of chemsex use and the perspectives on factors influencing chemsex initiation/discontinuation, effects on physical health, mental health and social outcomes, and the necessary services for a comprehensive chemsex clinic among YMSM; and the acceptability and feasibility of developing a comprehensive chemsex clinic from the perspective of YMSM, their family members or peers, and clinic staff.

This phase II study (CLYMAX-2) will be a prospective cohort study using a quantitative data collection exploring the effectiveness of the implementation strategy of harm reduction models and consist of a larger number of YMSM, important baseline and follow-up information on multiple aspects of physical, psychological, and social harms.

Enrollment

150 estimated patients

Sex

Male

Ages

16 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Men who have sex with men
  2. Aged 16-35 years
  3. Current chemsex users (defined as last chemsex used within 3 months)
  4. Able to read and communicate in Thai
  5. Provide informed consent

Exclusion criteria

None

Trial contacts and locations

2

Loading...

Central trial contact

Nittaya Phanuphak, MD.,PhD; Jakkrapatara Boonruang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems